Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Glisulin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 84Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Remedy Pharmaceuticals Gets U.S. Patent for CIRARA
    Remedy Pharmaceuticals Gets U.S. Patent for CIRARA

    18 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-secures-key-us-patent-allowance-for-cirara-in-treating-large-hemispheric-infarction-including-wake-up-strokes-302401375.html

    PR NEWSWIRE
    18 Mar 2025
    Share Share
    Enforcement Report - Week of January 29, 2025
    Enforcement Report - Week of January 29, 2025

    29 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-29-2025-5490.pdf

    FDA
    29 Jan 2025
    Share Share
    Eton Pharmaceuticals Acquires U.S. Rights to Amglidia Suspension
    Eton Pharmaceuticals Acquires U.S. Rights to Amglidia Suspension

    25 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/25/2986515/0/en/Eton-Pharmaceuticals-Announces-Acquisition-of-U-S-Rights-to-Amglidia-Glyburide-Oral-Suspension.html

    GLOBENEWSWIRE
    25 Nov 2024
    Share Share
    Remedy Pharmaceuticals' Phase 3 Stroke Trial Shows Significant Effect
    Remedy Pharmaceuticals' Phase 3 Stroke Trial Shows Significant Effect

    01 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-phase-3-trial-in-large-lesion-stroke-patients-demonstrates-statistically-significant-effect-at-one-year-302260511.html

    PR NEWSWIRE
    01 Oct 2024
    Share Share
    Remedy Gets Acute Stroke Drug Back Shows Positive Subgroup Analysis
    Remedy Gets Acute Stroke Drug Back Shows Positive Subgroup Analysis

    30 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-gets-rights-to-acute-stroke-drug-back-from-biogen-announces-clinically-meaningful-and-statistically-significant-results-from-pre-specified-subgroup-and-post-hoc-analyses-of-phase-3-study-302157095.html

    PR NEWSWIRE
    30 May 2024
    Share Share
    SugarMDs LLC Issues Voluntary Nationwide Recall of Advanced Glucose Support Supplements Capsules Due to Presence of Undeclared Glyburide and Metformin
    SugarMDs LLC Issues Voluntary Nationwide Recall of Advanced Glucose Support Supplements Capsules Due to Presence of Undeclared Glyburide and Metformin

    15 Nov 2023

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sugarmds-llc-issues-voluntary-nationwide-recall-advanced-glucose-support-supplements-capsules-due

    FDA
    15 Nov 2023
    Share Share